Documente Academic
Documente Profesional
Documente Cultură
Assessment of Immune
Function
Immune System
Antibody
An antibody is a protein substance developed by
the body in response to and interacting with a
specific antigen.
Antigen
A substance that induces the production of
antibody
Immunoglobulins
Antibodies (protein molecules IgA, E, G, M,
D)
Immune Function
Natural immunity: nonspecific response to
any foreign invader
Allergic Reactions
Allergy
An inappropriate often harmful response of
the immune system to normally harmless
substances
Hypersensitive reaction to an allergen
initiated by immunological mechanisms
which is usually mediated by IgE antibodies
Hypersensitivity
Medication
Oxygen, if respiratory need
Epinephrine used for anaphylactic
reactions
Antihistamines (benadryl, zrytec,
claratine)
Corticosteroids (prednasone)
Management of Patients
With Immunodeficiency
Immunodeficiency Disorders
Primary: genetic
Inborn errors of immune function
May effect phagocytic function, B cells and/or
T cells, or the complement system
E.g DiGeorge Syndrome, IgA deficiency,
Wiscot Aldrich Syndrome (thrombocytopenia),
phagocytic disorders
Secondary
Acquired
Related to underlying disorders, diseases,
toxic substances, or medications
HIV/AIDS, autoimmune disorders e.g SLE,
Primary Immunodeficiency
Usually seen in infants and young children
Manifestations: vary according to type,
severe or recurrent infections, failure to
thrive or poor growth, positive family
history
Potential complications: recurrent, severe,
potentially fatal infections; related blood
dyscrasias or malignancies
Treatment: varies by type, treatment of
infection, immunoglobulin Rx, stem cell or
bone marrow transplant
Nursing Management
Monitor for signs and symptoms of
infections
Monitor lab values
Promote good nutrition
Address anxiety, stress, and coping
Strategies to reduce risk of infection
Handwashing and strict aseptic technique
Patient protection and hygiene measures: skin
care, promote normal bowel and bladder
function, pulmonary hygiene
Patient Teaching
Signs and symptoms of infection
Medication
Prevention of infection
Hand washing
Avoid crowds and persons with infections
Hygiene and cleaning
HIV/AIDS Infection
Human immunodeficiency virus is a
member of the retrovirus family that
causes AIDS.
Characterized by long incubation period
Carries genetic material in form of RNA
Transmission of HIV
Transmitted by body fluids containing
HIV or infected CD4 lymphocytes
Blood, seminal fluid, vaginal secretions,
amniotic fluid, and breast milk
Most prenatal infections occur during
delivery
High-Risk Behaviors
Sharing infected injection equipment
Having sexual relations with infected
individuals
Prevention
Standard precautions
Safer sex practices and safer
behaviors
Abstinence
Reduce the number of sexual
partners to one
Always use latex condoms; if allergic
to latex, use non-latex condoms
Standard Precautions
Standard precautions infection control
practices used to prevent transmission of
diseases that can be acquired by contact
with blood, body fluids, non-intact skin.
Hand hygiene
Personal Protective Equipment (PPE)
Respiratory hygiene
Proper disposal of soiled material
Environmental control
Disposal of sharps
Primary Infection
AKA acute HIV infection/acute HIV
syndrome
Period from infection to development
of HIV antibodies
Symptoms: none to flu-like syndrome
Period of rapid viral replication and
dissemination through the body
CD4+ (500 1500 cells/mm3)
HIV Asymptomatic
More than 500 CD4+ T
lymphpocytes/mm3
Chronic asymptomatic state
begins
Body has sufficient immune
response to defend against
pathogens
Individual is relatively well
HIV Symptomatic
200499 CD4+ lymphpocytes/mm3
CD4 T cells gradually fall
The patient develops symptoms or
conditions related to the HIV infection
Conditions are classified as category
B conditions
Oral candidiasis
Cervical dysplasia
Herpes zoster (shingles)
Fever, diarrhea x 1/12
AIDS
Less than 200 CD4+ lymphocytes/mm3
As levels drop below 100 cell/mm3 the
immune system is significantly
impaired
Development of category C conditions
Candidiasis of esophagus, lungs
Cervcal cancer
Kaposis sarcoma
Pneumoncystis pneumonia
Wasting syndrome
Diagnostic Tests
Enzyme immunoassay (ELISA) test to identify HIV
antibodies
Western Blot detects HIV antibodies & confirms
EIA
Viral Load Measures HIV RNA in plasma
CD4 / CD8 monitors the function of immune
systems and tracts the progression of the disease
Measures the ratio between the CD4 on helper T cells
and the CD8 on suppressor and cytotoxic T cells
Orasure (saliva)
OraQuick
Clinical Manifestations of
HIV/AIDS
Respiratory
1.Pneumocystic carini pneumonia (PCP):
Clinical Manifestations
Gastrointestinal
1.Oral candidiasis
3.Wasting syndrome
Clinical Manifestations
Kaposi's sarcoma
Cutaneous lesions, but may involve
multiple organ systems
Lesions cause discomfort, disfigurement,
ulceration, and potential for infection
B-cell lymphomas
Clinical Manifestations
Neurologic
1.HIV encephalopathy
Progressive cognitive, behavioral,
and motor decline
2.Cryptococcus neoformans
fungal infection that can cause
meningitis
3.Depression
Treatment
Treatment and protocols are continually evolving
Antiretroviral agents
Nucleoside reverse transcriptase inhibitors (NRTIs)
Non-nucleoside reverse transcriptase inhibitors
(NNRTIs)
Protease inhibitors (PIs)
Fusion inhibitors
Use of combination therapy
Management also focuses upon the treatment of
specific manifestations and conditions related to the
disease
Terminology
ART =
AntiRetroviral Therapy
ARV =
AntiRetroVirals
HAART =
Highly Active
AntiRetroviral
Therapy
Triple Therapy = Three Antiretrovirals
The Cocktail
becoming available
through clinical trials.
Always use 3 or
more different ARV
medications for
therapy.
Regimen should be
selected by an
experienced HCW.
Other medications
interact with ARVs.
Advantages of ARV
Therapy
Improved
patient health
Reduced illness
Reduced
hospitalisations
Fewer deaths
from AIDS
CD4 Count
Viral Load
Time
Use of ARVs
The Stage of HIV depends upon:
Immunological markers (CD4 count)
Clinical symptoms (Opportunistic
infections)
It also depends on whether the patient is
READY to start
ARVs
Blood Samples
Correct clinical decisions depend on
meaningful clinical laboratory information
Nurses have a direct responsibility to
ensure that accurate results are obtained
which may inform appropriate clinical
decisions
This depends on proper specimen collection
Common blood tests:
CD4 Count
Viral Load
Monitoring Labs (FBC, LFTs)
Resistance Testing
anaemia, headache,
neutropenia, fatigue
3TC (Epivir):
d4T (Zerit):
ddI (Videx):
rash,
sedative effects, headache, nausea,
diarrhoea, vivid dreams, insomnia,
increase LFTs, hepatitis,
Nevirapine (Viramune):
headache,
nausea, rash, diarrhoea, increase
LFTs, hepatitis, liver failure
Other toxicities..
Regular monitoring of blood
CBC/FBC
levels
is essential to
Liver function
identify ARV toxicities
Kidney function
Appropriate intervention
can then be made
Cholesterol
Glucose
Our Role
As nurses, we have a vital role to
play in ensuring side effects are
How do we do this?........
Educating patients
Prompt recognition and reporting
Understanding lab tests and results
Explaining lab tests to patients
Therapeutic intervention
Providing support and counselling for
patient and family
Ensuring follow up of patients
Educating the general public
Collaborative Problems/Potentia
Complications
Opportunistic infections
Impaired breathing or respiratory
failure
Wasting syndrome
Fluid and electrolyte imbalance
Adverse reaction to medication
Opportunistic Infections
An opportunistic infection is an
infection caused by pathogens, particularly
opportunistic pathogens (bacterial, viral,
fungal or protozoan) that usually do not
cause disease in a healthy host.
Parasitic
Pneumocystis carinii
Fungal
Candida
Cryptococcus
Opportunistic Infections
Bacterial
Tuberculosis (TB)
Strep pneumonia
Viral
Kaposi Sarcoma
Herpes
Influenza (flu)
Nursing Management:
Assessment
Assess physical and psychosocial status
Identify potential risk factors: IV drug
abuse, risky sexual practices
Immune system function
Nutritional status
Skin integrity
Respiratory & neurologic status
Fluid and electrolyte balance
Knowledge level
Skin Integrity
Frequent routine assessment of skin
and mucosa
Reposition at least every 2 hours and
as needed
Pressure reduction devices
Instruct patient to avoid scratching
Use gentle, nondrying soaps or
cleansers
Avoid adhesive tape
Perianal skin care
Activity Intolerance
Maintain balance between
activity and rest
Instruction regarding energy
conservation techniques
Relaxation measures
Strengthening muscles
Nutrition
Monitor weight, I&O, dietary intake,
and factors that interfere with
nutrition
Dietary consult
Control of nausea with antiemetics
Oral hygiene
Treatment of oral discomfort
Dietary supplements
May require enteral feedings or
parenteral nutrition
Decreasing Isolation
Promote an atmosphere of
acceptance and understanding
Assess social interactions and
monitor behaviors
Allow patient to express feelings
Address psychosocial issues
Provide information related to the
spread of infection
Educate ancillary personnel, family,
and partners
Other Interventions
Improving airway clearance
Position in semi-Fowler's or high
Fowlers
Pulmonary therapy; coughing and
deep breathing, postural drainage,
percussion, and vibration
Ensure adequate rest
Pain
Medications as prescribed
Skin and perianal care
Prevention of Infection
Hand Hygiene
Proper washing of hands
Prevention of Infection
Minimize visitors with infections
because of pts. Immune response
Use strict asepsis for all invasive
procedures
Prevention of Infection
Ensure pts. environment is kept clean
to prevent transfer of organisms
Educate pt. on importance of hand
washing, clean environment to
prevent transmission of organisms
Ensuring pt. receives a nutritionally
balanced diet for maintenance of
immune system
Administration of anti infectives if
prescribed
Objectives
By the end of this session you should be
able to:
Define the term SLE
Identify the etiology of SLE
Explain the pathiphysiology of SLE;
Discuss the signs and symptoms of SLE;
and
Discuss the medical and nusring
management of SLE.
Systemic Lupus
Erythematosus (SLE)
Incidence
SLE affects 2 to 8 persons per 100,000 in
United States
Most cases occur in women of
childbearing years
Peak incidence occurs between 15
40yrs.
Female to male ratio of 9:1
African, Asian, Hispanic, and Native
Americans three times more likely to
develop than whites
Etiology
Etiology is unknown
Most probable causes
Genetic influence
Hormones
Environmental factors (ultra violet light)
Certain medications
Hydralazine, procainanmide
Quinidine, methyldopa, isoniazid, phenytoin
SLE: Pathophysiology
There is a disturbed immune
regulation that causes an over
production of autoantibodies
This disturbance is caused by a
combination of factors:
Genetic
Hormonal
Environmental
Medication
Pathophysiology contd.
Abnormal suppressor T cell function
causes the increase in autoantibody
production
The autoantibodies combine with
antigens to form immune complexes
The immune complexes are
deposited in vascular and tissue
surfaces which triggers an
inflammatory response
The inflammatory process leads to
tissue damage
Clinical Manifestations
Onset may be acute (sudden) or
insidious (gradual)
Ranges from a relatively mild disorder to
rapidly progressing
Can affect any body system
Most commonly affects the skin/muscles,
lining of lungs, heart, nervous tissue,
and kidneys
Characterized by exacerbations and
remission
Clinical Manifestations
Fig 65-9
Clinical Manifestations
Dermatologic
Cutaneous vascular lesions
Discoid LE (chronic rash)
Butterfly rash
Oral/nasopharyngeal ulcers
Alopecia
Clinical Manifestations
Musculoskeletal
Polyarthralgia with morning stiffness
Arthritis
Swan neck fingers
Ulnar deviation
Subluxation with hyperlaxity of joints
Clinical Manifestations
Renal
Lupus nephritis
Ranging from mild proteinuria to
glomerulonephritis
Primary goal in treatment is slowing the
progression
Clinical Manifestations
Nervous system
Generalized/focal seizures
Peripheral neuropathy
Cognitive dysfunction
Disorientation
Memory deficits
Psychiatric symptoms
Diagnostic Studies
No specific test
SLE is diagnosed primarily on criteria
relating to patient history, physical
examination, and laboratory findings
Diagnostic Tests
Collaborative Care
Goals:
Early diagnosis
Preventing loss of organ fucntions
Minimize disease related disabilities
Preventing complicaitons from therapy
Antimalarial drugs
Controls disease by decreasing
bodies production of antigens
Nursing Management
Nursing Diagnoses
Fatigue
Acute pain
Impaired skin integrity
Ineffective therapeutic regimen
management
Body image disturbance
Nursing Management
Planning
Overall goals
Have satisfactory pain relief
Comply with therapeutic regimen to
achieve maximum symptom management
Demonstrate awareness of, and avoid
activities that cause disease exacerbation
(triggers)
Maintain optimal role function and a
positive self-image
Nursing Management
Nursing Implementation
Acute intervention
During exacerbation, patient will
become abruptly, dramatically ill
Record severity of symptoms and
response to therapy
Nursing Management
Nursing Implementation
Acute intervention (contd)
Observe for
Fever pattern
Joint inflammation
Limitation of motion
Location and degree of discomfort
Fatigability
Nursing Management
Nursing Implementation
Acute intervention (contd)
Monitor weight and I&O
Collect 24-hour urine sample
Assess neurological status
Explain nature of disease
Provide support
Nursing Management
Nursing Implementation
Ambulatory and home care (Discharge)
Reiterate that adherence to treatment
does not necessarily halt progression
Minimize exposure to precipitating factors
fatigue, sun, stress, infection, drugs
Teach energy conservation and relaxation
exercises
For joint problems, all the teaching for RA
related to joint protection, ROM, and
positioning to prevent contractures
Nursing Management
Nursing Management
Lupus and pregnancy
Infertility can result from SLE treatment
regimen
SLE is associated with complications of
pregnancy
Pregnancy & post partum can cause
exacerbations of SLE
Women with serious SLE should be
counseled against pregnancy
Nursing Management
Psychosocial issues
Counsel patient and family that SLE has
good prognosis
Physical effects can lead to isolation,
self-esteem, and body image
disturbances
Assist patient in developing goals
Nursing Management
Evaluation
Expected outcomes
Performance of activities of daily
living without pain
Limitation of direct exposure to sun
and use of sunscreen
No open skin lesions
Nursing Management
Evaluation
Expected outcomes (contd)
Expression of satisfaction with
activity level
Pacing of activities to match level of
tolerance
Expression of confidence in ability to
manage SLE over time and in home
environment